Janus Henderson Group’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $334K | Hold |
19,854
| – | – | ﹤0.01% | 2171 |
|
|
2025
Q4 | $318K | Hold |
19,854
| – | – | ﹤0.01% | 2185 |
|
|
2025
Q3 | $246K | Hold |
19,854
| – | – | ﹤0.01% | 2280 |
|
|
2025
Q2 | $229K | Hold |
19,854
| – | – | ﹤0.01% | 2277 |
|
|
2025
Q1 | $304K | Hold |
19,854
| – | – | ﹤0.01% | 2199 |
|
|
2024
Q4 | $344K | Hold |
19,854
| – | – | ﹤0.01% | 2197 |
|
|
2024
Q3 | $368K | Hold |
19,854
| – | – | ﹤0.01% | 2173 |
|
|
2024
Q2 | $402K | Sell |
19,854
-240
| -1% | -$4.25K | ﹤0.01% | 2084 |
|
|
2024
Q1 | $343K | Buy |
20,094
+1
| +0% | +$16 | ﹤0.01% | 2176 |
|
|
2023
Q4 | $355K | Sell |
20,093
-35
| -0.2% | -$705 | ﹤0.01% | 2154 |
|
|
2023
Q3 | $483K | Buy |
20,128
+1
| +0% | +$25 | ﹤0.01% | 1936 |
|
|
2023
Q2 | $468K | Buy |
20,127
+273
| +1% | +$6.17K | ﹤0.01% | 2016 |
|
|
2023
Q1 | $438K | Buy |
+19,854
| New | +$465K | ﹤0.01% | 2093 |
|
|
2022
Q2 | – | Sell |
-8,771
| Closed | -$277K | – | 2608 |
|
|
2022
Q1 | $277K | Buy |
+8,771
| New | +$246K | ﹤0.01% | 2270 |
|
|
2019
Q1 | – | Sell |
-5,420
| Closed | -$323K | – | 1350 |
|
|
2018
Q4 | $323K | Hold |
5,420
| – | – | ﹤0.01% | 1265 |
|
|
2018
Q3 | $628K | Sell |
5,420
-2,004
| -27% | -$226K | ﹤0.01% | 1302 |
|
|
2018
Q2 | $937K | Buy |
7,424
+5,304
| +250% | +$646K | ﹤0.01% | 1233 |
|
|
2018
Q1 | $229K | Hold |
2,120
| – | – | ﹤0.01% | 1333 |
|
|
2017
Q4 | $232K | Sell |
2,120
-8,144
| -79% | -$813K | ﹤0.01% | 1277 |
|
|
2017
Q3 | $1.01M | Buy |
10,264
+5,262
| +105% | +$510K | ﹤0.01% | 1183 |
|
|
2017
Q2 | $506K | Buy |
5,002
+64
| +1% | +$6.9K | ﹤0.01% | 1241 |
|
|
2017
Q1 | $571K | Hold |
4,938
| – | – | ﹤0.01% | 761 |
|
|
2016
Q4 | $593K | Buy |
4,938
+700
| +17% | +$77.5K | ﹤0.01% | 766 |
|
|
2016
Q3 | $476K | Hold |
4,238
| – | – | ﹤0.01% | 773 |
|
|
2016
Q2 | $525K | Sell |
4,238
-2,655
| -39% | -$321K | ﹤0.01% | 748 |
|
|
2016
Q1 | $775K | Hold |
6,893
| – | – | 0.01% | 700 |
|
|
2015
Q4 | $749K | Hold |
6,893
| – | – | 0.01% | 692 |
|
|
2015
Q3 | $687K | Hold |
6,893
| – | – | 0.01% | 698 |
|
|
2015
Q2 | $786K | Hold |
6,893
| – | – | 0.01% | 722 |
|
|
2015
Q1 | $720K | Hold |
6,893
| – | – | 0.01% | 740 |
|
|
2014
Q4 | $830K | Hold |
6,893
| – | – | 0.01% | 728 |
|
|
2014
Q3 | $1.01M | Hold |
6,893
| – | – | 0.01% | 606 |
|
|
2014
Q2 | $1.15M | Hold |
6,893
| – | – | 0.01% | 569 |
|
|
2014
Q1 | $1.37M | Buy |
6,893
+3,320
| +93% | +$627K | 0.01% | 526 |
|
|
2013
Q4 | $682K | Hold |
3,573
| – | – | 0.01% | 638 |
|
|
2013
Q3 | $605K | Hold |
3,573
| – | – | 0.01% | 648 |
|
|
2013
Q2 | $541K | Buy |
+3,573
| New | +$506K | 0.01% | 644 |
|
Other funds holding CLB
AI
DGI
CAMG
VCM
VPM
Janus Henderson Group's CLB Position: Q1 2026 in Review
Janus Henderson Group held its Core Laboratories (CLB) position steady in Q1 2026 at 19,854 shares worth $334K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.
Janus Henderson Group first reported a position in CLB in Q2 2013 and has held it in 37 quarters since. The position peaked at $1.37M in Q1 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.
- Janus Henderson Group held 19,854 shares of Core Laboratories worth $334K as of Q1 2026.
- Janus Henderson Group left its Core Laboratories share count unchanged in Q1 2026.
- Core Laboratories made up ﹤0.01% of Janus Henderson Group's portfolio in Q1 2026, its #2171 holding.
- Janus Henderson Group first reported a position in Core Laboratories in Q2 2013 and has held it in 37 quarters since.
- Janus Henderson Group's Core Laboratories position peaked at $1.37M in Q1 2014.
- 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.